a public good project by the
Synthesis
Company
of California

© 2026

Zhonghua Du | doi.page

0 works0 citations0 h-index

Zhonghua Du

Shantou University(CN)Affiliated Hospital of Shandong University of Traditional Chinese Medicine(CN)Shandong Academy of Chinese Medicine(CN)

Publications by Year

Research Areas

Cancer-related molecular mechanisms research, CRISPR and Genetic Engineering, RNA Research and Splicing, MicroRNA in disease regulation, RNA modifications and cancer

Most-Cited Works

→ A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1(2018)470 cited
→ Epigenetic Targeting of Granulin in Hepatoma Cells by Synthetic CRISPR dCas9 Epi-suppressors(2018)75 cited
→ STAT3 induces muscle stem cell differentiation by interaction with myoD(2009)52 cited
→ Targeting the IGF1R Pathway in Breast Cancer Using Antisense lncRNA-Mediated Promoter cis Competition(2018)48 cited
→ Mitochondrial DNA Hypomethylation Is a Biomarker Associated with Induced Senescence in Human Fetal Heart Mesenchymal Stem Cells(2017)47 cited
→ Genome-wide interaction target profiling reveals a novel Peblr20-eRNA activation pathway to control stem cell pluripotency(2019)36 cited

→ Profiling the long noncoding RNA interaction network in the regulatory elements of target genes by chromatin in situ reverse transcription sequencing(2019)

35 cited

→ Identification of complement C3f‐desArg and its derivative for acute leukemia diagnosis and minimal residual disease assessment(2009)27 cited

→ Chromatin lncRNA Platr10 controls stem cell pluripotency by coordinating an intrachromosomal regulatory network(2021)27 cited

→ Oplr16 serves as a novel chromatin factor to control stem cell fate by modulating pluripotency-specific chromosomal looping and TET2-mediated DNA demethylation(2020)26 cited